Midday Report: Tabula Rasa HealthCare (TRHC) Shares Up on June 23

Equities Staff  |

Today Tabula Rasa HealthCare Inc (NASDAQ: TRHC) is trading 5.74% higher.

The latest price, as of 12:13:32 est, was $3.11. Tabula Rasa HealthCare has climbed $0.17 so far today.

183,297 shares have been traded today.

As of the previous close, Tabula Rasa HealthCare has a YTD change of 80.27%. The company expects its next earnings on 2022-08-04.

For technical charts, analysis, and more on Tabula Rasa HealthCare visit the company profile.

About Tabula Rasa HealthCare Inc

Tabula Rasa HealthCare provides medication safety solutions that empower healthcare professionals to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. TRHC's technology solutions, including DoseMeRx™ and MedWise™, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based payment results.

To get more information on Tabula Rasa HealthCare Inc and to follow the company's latest updates, you can visit the company's profile page here: Tabula Rasa HealthCare Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade

Market Movers

Sponsored Financial Content